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起糜烂性胃炎患者非常重要。随机抽取 2014 年 9月～








[摘要] 目的 分析和探讨采用益气化浊和胃方临床治疗慢性隆起糜烂性胃炎患者的情况及效果。 方法 随机抽
取 2014 年 9月～2015年 9月间在我院中医科进行诊治的 78例慢性隆起糜烂性胃炎患者。 根据抽签法将其平均
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[Abstract] Objective To analyze and explore the situation and effect of Yiqi Huazhuo Hewei decoction in the clinical
treatment of patients with chronic uplift erosive gastritis. Methods A total of 78 patients with chronic uplift erosive
gastritis diagnosed and treated in the Department of Traditional Chinese Medicine of our hospital from September 2014
to September 2015 were randomly selected. They were averaged into two groups according to the lottery method, with
39 patients in each group. One group was treated with western medicine alone(control group) and the other group was
given Chinese medicine Yiqi Huazhuo Hewei decoction treatment(observation group). The symptom scores, clinical cura-
tive effect and adverse reaction rate of patients with chronic uplift erosive gastritis between two groups were recorded
and compared. Results The results of this study showed that the clinical symptom scores and the adverse reactions rate
of patients with chronic erosive gastritis in the observation group were lower than those in the control group, and there
was significant difference between the two groups(P<0.05). The total effective rate(94.87%) in the observation group was
higher than that in the control group(79.49%), and the difference between the two groups was significant(P<0.05).
Conclusion The application of Chinese medicine Yiqi Huazhuo Hewei decoction in the treatment of the chronic uplift
of patients with erosive gastritis can promote can improve the treatment effect in clinical, and make the clinical symp-
toms of patients effectively alleviated. And it also can reduce the pain of patients, and improve clinical cure rate. So it
is a scientific, effective, safe and ideal clinical diagnosis and treatment method.
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本次研究选择的对象为 2014 年 9 月～2015 年
9 月间在我院中医科接受治疗的 78 例慢性隆起糜烂
性胃炎患者，均经胃镜和病理检查确诊为慢性隆起糜
烂性胃炎。 慢性隆起糜烂性胃炎患者年龄 17~66 岁，
平均（45.72±5.87）岁，男女比例为 43:35，病程 1~8 年，
平均（2.34±0.52）年。 通过抽签法将 78 例患者进行随
机分组，随机平均分为两组。对照组：男 21例，女 18例，
年龄 17~64 岁，平均（45.25±5.80）岁，病程 1~7 年，平
均（2.25±0.48）年。 胃镜检查分级情况：Ⅰ级 21 例，Ⅱ
级 12例，Ⅲ级 6 例。 观察组：男 22 例，女 17 例，年龄
18~66 岁 ，平均 （45.73±5.89）岁 ；病程 2~8 年 ，平均







1.2.1 西医临床诊断标准 参照消化内镜学会于 2003
年在大连会议上制定的慢性胃炎内镜分型分级标准
进行诊断。














H20113067，规格：20 mg/片）20 mg/次，2 次/d；口服瑞
巴派特片（通用名称：瑞巴派特片，生产商家：浙江大
冢制药有限公司，国药准字 H20020541，规格：0.1 g/




口服克拉霉素 （通用名称 ：克拉霉素分散片 ，生产




H20113067，规格：20 mg/片）20 mg/次 ，2 次/d，服药
1周。
1.4.2 观察组 患者采用中医益气化浊和胃方进行临
床治疗。 即药方为：煅瓦楞 45 g，煅牡蛎 45 g，败酱草
30 g，红藤 30 g，生黄芪 24 g，姜半夏 12 g（先），白及
18 g，莪术 12 g，三棱 12 g，苏梗 10 g，制南星 10 g
（先），枳壳 6 g，姜川连 3 g，黄芩 3 g，炙甘草 3 g，制大
黄 3 g。 冷水煎服，1剂分两次在早、晚服用，治疗时间
为 4周。
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不良反应 观察组（n=39） 对照组（n=39） χ2值 P 值
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